MedPath

NOVA PHARMACEUTICALS AUSTRALASIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

302

TGA:302

Drug Approvals

COLES GAS RELIEF simethicone 200mg soft gelatin capsules blister pack (491326)

Product Name
COLES GAS RELIEF simethicone 200mg soft gelatin capsules blister pack
Approval Date
Jun 10, 2025
TGA

TRAVELMED tablet blister pack (490795)

Product Name
TRAVELMED tablet blister pack
Approval Date
Jun 4, 2025
TGA

CANDAZOLE clotrimazole 20 mg/g (2%) cream tube (490796)

Product Name
CANDAZOLE clotrimazole 20 mg/g (2%) cream tube
Approval Date
Jun 4, 2025
TGA

URALEEV methenamine hippurate 1g tablet bottle (490526)

Product Name
URALEEV methenamine hippurate 1g tablet bottle
Approval Date
May 30, 2025
TGA

NOVAZET abiraterone acetate 250 mg tablet bottle (449611)

Product Name
NOVAZET abiraterone acetate 250 mg tablet bottle
Approval Date
Apr 30, 2025
TGA

VOSTIG abiraterone acetate 250 mg tablet bottle (449615)

Product Name
VOSTIG abiraterone acetate 250 mg tablet bottle
Approval Date
Apr 30, 2025
TGA

ZYRON abiraterone acetate 250 mg tablet bottle (449613)

Product Name
ZYRON abiraterone acetate 250 mg tablet bottle
Approval Date
Apr 30, 2025
TGA

ZYRON abiraterone acetate 500 mg tablet blister pack (449614)

Product Name
ZYRON abiraterone acetate 500 mg tablet blister pack
Approval Date
Apr 30, 2025
TGA

VOSTIG abiraterone acetate 500 mg tablet blister pack (449616)

Product Name
VOSTIG abiraterone acetate 500 mg tablet blister pack
Approval Date
Apr 30, 2025
TGA

NOVAZET abiraterone acetate 500 mg tablet blister pack (449612)

Product Name
NOVAZET abiraterone acetate 500 mg tablet blister pack
Approval Date
Apr 30, 2025
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 31
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.